Cell No. : Cell Name
RCB6012 : HUDEP-2-HBG1-HiBiT
update : 2025/03/13
|
Comment | Currently not ready. |
Comment from the depositor | A derivative cell line of HUDEP-2 (RCB4557) expressing HBG1-HiBiT. |
Terms and conditions | |
Remarks | CRISPR/Cas9 genome edited bioresources Announcement of bioresources developed by the CRISPR/Cas9 technology. |
Order Form |
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
Basic information
|
Expected time |
Upon a request we will start preparation. Contact us: cellkitaku.brc@riken.jp
|
IPR |
Erasmus MC (Netherlands) & RIKEN BioResource Research Center (Japan)
|
Reference information |
Reference |
0
|
User's Publication |
0
|